RARE DISEASERESEARCH ATLAS

ORPHA:141242

Paramedian nasal cleft

high confidenceDisorder

Also known as: Alar cleft · Alar rim cleft · Cleft nose · Isolated cleft of the ala nasi · Isolated coloboma of the nose · Tessier number 1 cleft

Publications

266

59.6th percentile

Trials

0

Interventional, condition-specific

Researchers

774

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

Clinical definition (Orphanet)

Paramedian nasal cleft is a rare developmental defect during embryogenesis characterized by a unilateral or bilateral coloboma of the nose, ranging in severity from a small notch, resulting in minor deviation of the nasal septum, to variable-sized clefts of the nasal ala which may be associated with small cysts or sinuses in the nasal midline. Defect may be isolated or may occur in association with cleft lip and/or other craniofacial anomalies (e.g. hypertelorism, broadening of nasal root, midline cleft). Dorsum and apex of nose are usually well preserved.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (5)

alar cleft · alar rim cleft · cleft nose · isolated cleft of the ala nasi · isolated coloboma of the nose

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    266 matched papers (120 in last 10 years) Source

  3. Phenotype characterisedNot found

    No HPO disease–phenotype associations via Monarch for these Mondo IDs

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

266

266 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

266 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

120 in the last 10 years · high confidence · 59.6th percentile (publications denominator)

Phrase hits: 266 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

774

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Rossell-Perry P8 papers · 2026

    Post Graduate Studies School of Medicine, San Martin de Porres University, Santa Anita, Peru; and Department of Plastic Surgery, Edgardo Rebagliati Hospital, Lima, Peru.

    Papers in Europe PMC
  2. 02
    Shi B6 papers · 2024

    State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

    Papers in Europe PMC
  3. 03
    Li J5 papers · 2024

    Department of Cleft Lip and Palate Surgery, West China Stomatology College, Sichuan University, State Key Laboratory of Oral Diseases, Chengdu, China.

    Papers in Europe PMC
  4. 04
    Lo LJ5 papers · 2023

    Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan 333, Taiwan. lunjoulo@cgmh.org.tw.

    Papers in Europe PMC
  5. 05
    Bonanthaya K4 papers · 2020

    Bhagwan Mahaveer Jain Hospital, Bangalore, India

    Papers in Europe PMC
  6. 06
    Bradley JP4 papers · 2021

    From the Division of Plastic and Reconstructive Surgery, University of California Los Angeles David Geffen School of Medicine; and Northwell Health Hofstra School of Medicine.

    Papers in Europe PMC
  7. 07
    Denadai R4 papers · 2023

    Department of Plastic and Reconstructive Surgery and Craniofacial Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan 333, Taiwan. denadai.rafael@hotmail.com.

    Papers in Europe PMC
  8. 08
    Gubisch W4 papers · 2011

    Department of Plastic and Reconstructive Surgery, Marienhospital, Stuttgart, Germany.

    Papers in Europe PMC
  9. 09
    Kehrer A4 papers · 2021

    Centre of Plastic, Aesthetic, Hand and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.

    Papers in Europe PMC
  10. 10
    Liao YF4 papers · 2015

    Taoyuan, Linkou, and Taipei, Taiwan From the Craniofacial Center and the Craniofacial Research Center, Chang Gung Memorial Hospital; the College of Medicine, Chang Gung University; the Department of Craniofacial Orthodontics, Chang Gung Memorial Hospital; the Department of Craniofacial Orthodontics; and the Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

high confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Uncertain / not reviewed (2)

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Paramedian nasal cleft — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Paramedian nasal cleft" OR "Alar cleft" OR "Alar rim cleft" OR "Cleft nose" OR "Isolated cleft of the ala nasi" OR "Isolated cleft of ala nasi" OR "Isolated coloboma of the nose" OR "Isolated coloboma of nose" OR "Tessier number 1 cleft"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Paramedian nasal cleft" OR "Alar cleft" OR "Alar rim cleft" OR "Cleft nose" OR "Isolated cleft of the ala nasi" OR "Isolated cleft of ala nasi" OR "Isolated coloboma of the nose" OR "Isolated coloboma of nose" OR "Tessier number 1 cleft"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T07:56:06.193Z